BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15178365)

  • 1. Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression.
    Overstreet DH; Keeney A; Hogg S
    Eur J Pharmacol; 2004 May; 492(2-3):195-201. PubMed ID: 15178365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression.
    Overstreet DH; Griebel G
    Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.
    Overstreet DH; Griebel G
    Pharmacol Biochem Behav; 2005 Sep; 82(1):223-7. PubMed ID: 16181667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
    Arborelius L; Skelton KH; Thrivikraman KV; Plotsky PM; Schulz DW; Owens MJ
    J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice.
    Bhutada P; Mundhada Y; Bansod K; Ubgade A; Quazi M; Umathe S; Mundhada D
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):955-60. PubMed ID: 20447436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression.
    Overstreet DH; Stemmelin J; Griebel G
    Pharmacol Biochem Behav; 2008 Jun; 89(4):623-6. PubMed ID: 18358519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression.
    El Khoury A; Gruber SH; Mørk A; Mathé AA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):535-40. PubMed ID: 16414167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression.
    Overstreet DH; Naimoli VM; Griebel G
    Pharmacol Biochem Behav; 2010 Aug; 96(2):206-10. PubMed ID: 20470817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice.
    Tanaka M; Telegdy G
    Brain Res Bull; 2008 Mar; 75(5):509-12. PubMed ID: 18355626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression.
    Bjørnebekk A; Mathé AA; Brené S
    Hippocampus; 2010 Jul; 20(7):820-8. PubMed ID: 19623606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat.
    Harro J; Tõnissaar M; Eller M
    Neuropeptides; 2001 Apr; 35(2):100-9. PubMed ID: 11384205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.
    Yamano M; Yuki H; Yasuda S; Miyata K
    J Pharmacol Exp Ther; 2000 Jan; 292(1):181-7. PubMed ID: 10604946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats.
    Tamburella A; Micale V; Navarria A; Drago F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1205-10. PubMed ID: 19596038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats.
    Przegaliński E; Filip M; Frankowska M; Zaniewska M; Papla I
    Neuropeptides; 2005 Oct; 39(5):525-33. PubMed ID: 16139885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?
    Nielsen DM
    Life Sci; 2006 Jan; 78(9):909-19. PubMed ID: 16122764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inositol treatment reduces depression-like immobility of Flinders Sensitive Line rats in the forced swim test.
    Einat H; Belmaker RH; Zangen A; Overstreet DH; Yadid G
    Depress Anxiety; 2002; 15(3):148-51. PubMed ID: 12001182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
    Nielsen DM; Carey GJ; Gold LH
    Eur J Pharmacol; 2004 Sep; 499(1-2):135-46. PubMed ID: 15363960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats.
    Hansson AC; Rimondini R; Heilig M; Mathé AA; Sommer WH
    J Psychopharmacol; 2011 Oct; 25(10):1378-87. PubMed ID: 21262856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression.
    Liebenberg N; Harvey BH; Brand L; Brink CB
    Behav Pharmacol; 2010 Sep; 21(5-6):540-7. PubMed ID: 20555254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.
    Hodgson RA; Higgins GA; Guthrie DH; Lu SX; Pond AJ; Mullins DE; Guzzi MF; Parker EM; Varty GB
    Pharmacol Biochem Behav; 2007 Mar; 86(3):431-40. PubMed ID: 17291571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.